Back to search
FDAFDA · Food and drugs·Recall number D-0549-2024

Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA

Published June 19, 2024 · Recall initiated: May 31, 2024

Summary

FDA records drug Class II recall D-0549-2024, published June 19, 2024 and initiated May 31, 2024. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 8 bottles; Lot: Lot # B2906961-042524, exp. date 02/26/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
Product was distributed to one medical facility.
Lot
Lot # B2906961-042524, exp. date 02/26/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA recalled?

Yes. FDA published recall D-0549-2024 on June 19, 2024. Reported hazard: Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

What should I do if I have this product?

Voluntary: Firm initiated · Letter